Skip to main content

What's new

What are going to be the big headlines for 2012? What will be the impact of Bydureon, the latest once-weekly drug for people with type 2 diabetes? Continue Reading »

Kelly thanks the FDA for keeping its holiday promise: an artificial pancreas guidance document by December 1… Continue Reading »

Although insulin pens don't often grab headlines as much as other diabetes devices, we were glad to hear news about... Continue Reading »

According to a recent ... Continue Reading »